TELA Bio Inc., a medical technology company specializing in soft-tissue reconstruction solutions, has appointed Jeffrey Blizard as its new President. The announcement marks a strategic move to strengthen the company's executive leadership team as it enters a new phase of growth. Blizard, who has been on TELA Bio's Board of Directors for the past year, brings significant industry experience from his previous roles, including his tenure as Global Head of Surgical Sales at Abiomed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.